3-[2-(1H-Imidazol-1-yl)phenyl]-1-[3-(trifluoromethyl)phenyl]urea

Catalog No.: 
ACRRLC761
CAS No.: 
68008-26-4
Molecular Formula: 
C17H13F3N4O
Molecular Weight: 
346.31
3-[2-(1H-Imidazol-1-yl)phenyl]-1-[3-(trifluoromethyl)phenyl]urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$106.00InquiryInquiry
1g90%$329.00InquiryInquiry
5g90%$1612.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[2-(1H-Imidazol-1-yl)phenyl]-1-[3-(trifluoromethyl)phenyl]urea
IUPAC Name1-(2-(1H-imidazol-1-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea
MDL No.MFCD05670507
Molecular FormulaC17H13F3N4O
Molecular Weight346.31
SMILESO=C(NC1=CC=CC=C1N2C=CN=C2)NC3=CC=CC(C(F)(F)F)=C3
InChI KeyQMDWLMGSOLAXFX-UHFFFAOYSA-N
Synonym3-[2-(1H-imidazol-1-yl)phenyl]-1-[3-(trifluoromethyl)phenyl]urea;Urea, N-[2-(1H-imidazol-1-yl)phenyl]-N'-[3-(trifluoromethyl)phenyl]-
CAS No.68008-26-4

Synthetic Route by SureRoute

1. ACRRLC761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACECQA768 route compound structure diagram
    ACECQA76826286-54-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRRLC761 route product structure diagram
    ACRRLC76168008-26-4
Inquiry

2. ACRRLC761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRAUC529 route compound structure diagram
    ACRAUC5292646-97-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRRLC761 route product structure diagram
    ACRRLC76168008-26-4
Inquiry

3. ACRRLC761 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACECQA768 route compound structure diagram
    ACECQA76826286-54-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRRLC761 route product structure diagram
    ACRRLC76168008-26-4
Inquiry

Comments (0)